phase method (11) . CT-3-reactive molecules were dissociated from the plate by incubation with 2% SDS with or without 2-ME (reducing or nonreducing conditions) at 37°C for 1 h, and examined by SDS-PAGE in the Laemmli system.
Enzymatic Treatment. Blood mononuclear cells were treated wtih 1 mg/ml trypsin, pronase, or neuraminidase at 37°C for 30 min as described (11) . For endoglycosidase-F treatment, the 12~I-immunocomplex was dissociated from microtiter wells by incubation with 100 mM Tris-HCI, pH 6.8, containing 1% SDS and 10 mM EDTA at 80°C for 20 rain. CT-3-reactive molecules were then digested with endoglycosidase-F at 37 °C for 4 h (9).
[SH]Thymidine Incorporation. Blood mononuclear cells were incubated with the stimulating agent in RPMI-1640 culture medium containing 5% FCS in fiat-bottomed microtiter plates at 37°C in a humdified atmosphere containing 5% CO2. After 3 d, the cells were pulsed with 1 #Ci [SH]thymidine for 18 h, and the samples were harvested using a semiautomatic cell harvester.
[~H]Thymidine incorporation was measured with a scintillation counter.
Results
Tissue Distribution of Lymphocytes Reactive with the CT-3 Antibody. Indirect immunofluorescence analysis revealed that CT-3 antibody reacted with ~30% of thymocytes, 70% of blood mononuclear cells, and 60% of splenocytes, but <1% of cells in the bursa and bone marrow (Fig. 1 a) . When blood mononuclear cells were surface stained either with CT-3, the M-4 anti-u mAb (10), or CT-3 plus M-4, 70, 23, and 93%, respectively, of the cells stained. This suggested that CT-3 + cells and IgM + cells belong to separate lymphocyte populations, a conclusion that was confirmed when cells were examined by two-color immunofluorescence for reactivity with CT-3 or M-4. CT-3 was also found to react with a T cell line (MDCC-CuI5/40), but not with the B cell lines (BK25, 249L4, 243L], 293B9) or a myeloid cell line (BM2) tested. CT-3 antigens were capped after crosslinkage by the antibody, suggesting that CT-3 reacts with a surface molecule on chicken T cells that has transmembrane connection to intracellular contractile elements. Quail lymphocytes, on the other hand, were not reactive with CT-3.
Biochemical Characterization of CT-3-reactive Molecules.
T r e a t m e n t of chicken T cells with trypsin or pronase abolished CT-3 immunofluorescence reactivity, while neuraminidase treatment increased the immunofluorescence intensity slightly (Fig. I b) . SDS-PAGE analysis of the CT-3-reactive molecules isolated from NP-40-solubilized T ceils revealed three bands of Mr 20,000, 19,000, and 17,000 under nonreducing conditions (Fig. 2a, lane i) . Under reducing conditions, the apparent sizes were not altered significantly (lane 5). Removal of Nlinked sugars from the isolated CT-3-reactive molecules by endoglycosidase-F treatment yielded two bands of Mr 17,000 and 16,000 (Fig. 2b, and lane 8) .
These results suggest that the Mr 20,000 and 19,000 proteins were deglycosylated and migrated as a single band of 16,000, while the Mr 17,000 protein was unaffected. Identical results were obtained when the CT-3-reactive molecules on thymocytes and the Cu 15/40 T-cell line were examined. When 125I-labeled avian T cells were solubilized with digitonin, CT-3 coprecipitated a polypeptide of Mr 92,000 under nonreducing conditions (Fig. 2a,  lane 2) , and two polypeptides of Mr 49,000 and 37,000 under reducing conditions (Fig. 2a, lane 6) . (Table I ). An unrelated IgG1 mAb conjugated to the beads had no demonstrable effect.
Ontogeny of CT-3 Expression. The expression of CT-3-reactive molecules on
thymocytes and splenocytes was examined by immunofluorescence microscopy from embryonic day 12 onward. The CT-3 antigen was present on -5% of thymus cells from 12-d chick embryos. The frequency of CT-3 + thymocytes increased to 25% on day 14, and remained relatively constant thereafter until hatching on day 21. After hatching, the frequency ofCT-3 ÷ thymocytes increased to 50% over the first week of life, then decreased to 20-30% throughout young adulthood (Fig. 3) . Splenic CT-3 + lymphocytes were occasionally observed in embryonic life, but their frequency remained at <1% until hatching. The frequency of CT3 + splenocytes progressively increased thereafter to reach 65% in young adults. Discussion These studies provide the first evidence for existence of a T3/TCR complex in a nonmammalian vertebrate. The avian T3 molecules consist of a complex of three polypeptides of MT 20,000, 19,000, and 17,000, two of which are Nglycosylated. Thus the chicken T3 complex appears remarkably similar to the T3 molecular complex in humans, which consists of two N-glycosylated polypeptides and a nonglycosylated polypeptide (1, 2) . The human T3 E polypeptide is resistant to cell surface labeling with 125I, but it can be radioiodinated via a hydrophobic labeling agent, and can be biosynthetically labeled (1). In contrast, the candidate T3 molecules in mouse consist of four or more polypeptides, all of which can be radioiodinated by the lactoperoxidase method (7) (8) (9) as is the case for the chicken T3 polypeptides. Further studies are needed to identify homologies of the chains among the different representative species.
The human T cell receptor was originally recognized with anticlonotypic antibodies (6, 12) . Its a (Mr 44,000) and /3 (MT 37,000) chains could also be identified as minor components in anti-T3 immunoprecipitates isolated from iodinated celt lysates (3, 4) . Using an improved extraction procedure (9), CT-3 coprecipitated an polypeptide of Mr 92,000 from T cell lysates, which could be reduced to two polypeptides of M~ 49,000 and 37,000. These results suggest the existence of a chicken TCR homolog containing a disulfide-linked heterodimer of a and ~ chains associated with T3 molecules on the T cell surface.
The T cell mitogenic effect of the CT-3 antibody on Sepharose beads provides further evidence that the antibody identifies the avian counterpart of the mammalian T3/TCR complex. The marginal effect of soluble CT-3 is probably due to low binding affinity of avian Fc receptors for mammalian Ig (13), as interactions of anti-human T3 antibodies with monocyte Fc receptors are important in their mitogenic effects on T cells.
Hemopoietic stem cells colonized the avian thymic rudiment in waves, the first of which is attracted to the epithelial thymus in 6.5-d-old chick embryos (14) . Expression of cell surface antigens marking T-lineage differentiation begins 5-6 d later, 80% of embryonic thymocytes expressing the thymus specific antigen CT-1 by the 14th embryonic day (11) . The CT-3 antibody was reactive with ~5% of thymocytes on the 12th day of egg incubation. By day 14, 25% of embryonic thymocytes expressed CT-3 molecules, and the Mr 92,000 heterodimet could be detected in the CT-3 immunoprecipitate (data not shown). The data suggest that a 5-6-d interval of intrathymic sojourn is required for hemopoietic stem cell progeny to reach the stage of T3/TCR expression, and another week of intrathymic residence before the CT-3 + cells begin to migrate to the spleen in significant numbers.
The CT-3 antibody, which identifies the T3 complex on chicken and not quail T cells, should be an ideal probe for examining the role of the T3/TCR complex in the development and function of T cells. Summary A mouse mAb, CT-3, recognizes on chicken T cells a complex of three polypeptides, Mr 20,000, 19,000, and 17,000, two of which are N-glycosylated. The CT-3 antibody is mitogenic for chicken T cells, and it coprecipitates two
